Two executives of a Texas-based healthcare-billing company pleaded guilty to participating in schemes that generated millions in false claims tied to COVID-19 test billing and athletic training services. Federal prosecutors said the coordinated conduct defrauded payors and that sentencing will be scheduled following investigation by the FBI and federal inspector general offices.

Two executives of a healthcare-billing company in the Eastern District of Texas admitted guilt for their roles in coordinated schemes that submitted millions of dollars in false claims to public and private payors. The conspiracies included improper COVID-19 testing billing and a separate athletic-training billing scheme that billed for services not rendered or materially misrepresented. According to prosecutors, the executives orchestrated submission of inflated claims, falsified patient or service data, and accepted proceeds that were funneled through company accounts to conceal the fraud. Investigators from the FBI and multiple federal inspector general offices developed evidence of the coordinated billing practices, internal communications, and financial flows that tied the defendants to the scheme. The defendants entered guilty pleas and face sentencing, with restitution and potential forfeiture to be addressed at that time. The case highlights federal priority on detecting pandemic-era and health-care billing fraud and underscores continued use of interagency investigative teams to trace complex financial misconduct in the healthcare sector.